In our previous study, we demonstrated that LMT-28 exerts a therapeutic effect on RA development by inhibiting the IL-6-induced signaling pathways [33]; however, it remains unclear whether LMT-28 has a regulatory effect on RA-FLS migration and invasion. The gene discussed is IL6; the disease is rheumatoid arthritis.